Apollomics, Inc. (NASDAQ:APLMW) Short Interest Down 38.9% in February

Apollomics, Inc. (NASDAQ:APLMW) saw a significant decline in short interest in February. As of February 15th, there was short interest totalling 4,400 shares, a decline of 38.9% from the January 31st total of 7,200 shares. Based on an average daily volume of 64,200 shares, the days-to-cover ratio is presently 0.1 days.

Apollomics Price Performance

APLMW stock remained flat at $0.01 during mid-day trading on Monday. The company’s stock had a trading volume of 1,340 shares, compared to its average volume of 23,807. Apollomics has a 1-year low of $0.01 and a 1-year high of $0.03. The company has a 50-day moving average price of $0.01 and a two-hundred day moving average price of $0.01.

Apollomics Company Profile

Apollomics, Inc, a biotechnology company, engages in the discovery and development of mono and combination oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. Its pipeline consists of various development-stage assets, including novel and humanized monoclonal antibodies that restore the body's immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.